Skip to main content
. 2021 Jan 28;11:2497. doi: 10.1038/s41598-021-81766-8

Figure 2.

Figure 2

Significant differences of Albumin CSF/Blood Serum-quotients (AlbuminQ n × 10–3) between DCM and controls, as sign of blood spinal cord barrier disruption in DCM patients. CSF cerebrospinal fluid, DCM Degenerative cervical myelopathy, TAAA thoracic aortic abdominal aneurysm. Italic values indicate significance level of p < .05.